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OBJECTIVES: To assess knowledge towards etiology, treatment and management
of HTN among hypertensive patients in Southern Punjab, Pakistan. METHODS: A
convenient sample of 400 HTN patients visiting public hospital in Bahawalpur was
selected for the study. A pre-validated, self administered questionnaire was used
for data collection. Analyseswere done by SPSS 16. RESULTS:A total of 89.9% of the
patients weremales with amean age of 35.69 years with 240 (60%) having bachelor
level of education. A total of 180 (45%) of the participants had income below Paki-
stan rupees 20,000 per month. 296 (74%) patients knew the values of normal Blood
Pressure. 160 (40%) knew the causes and symptoms of HTN. 188 (47%) of patients
had hypertensive patients in their families; 308 (77.75%) thought that there should
be life style modifications in case of HTN and also stated that HTN is curable.
Majority of patients 216 (54%) did not monitor their blood pressure regularly and
were depending on signs and symptoms. A total of 139 patients (34.78%) became
hypertensive after the age of 30 years while 130 (32.61%) got the disease after the
age of 20. All patients were receiving allopathic treatment but only 130 (30%) were
following special diet program. A small number 100 (25%) of patients were receiv-
ing counseling services from health care professionals where as 316 (79%) were
depending upon opinions from friends, peers and patients already suffering from
HTN. CONCLUSIONS: The study results identified a strong need for education pro-
gram regarding HTN at the community level. The interaction between patients and
health care providers should be increased in order to have maximum therapeutic
outcome. Further studies are recommended to identify the contributing factors in
the treatment and management of HTN.
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EFFECT OF ACEI AND ARB ON HEALTH RELATED QUALITY OF LIFE IN
PATIENTS WITH HYPERTENSION AND DIABETES
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OBJECTIVES: To assess the effect of angiotensin converting enzyme inhibitors
(ACEI) and angiotensin receptor blockers (ARB) on health related quality of life
(HRQoL) in patients with hypertension and diabetes.METHODS:Medical Expendi-
ture Panel Survey (MEPS) 2002-2007 was used for the study. Each panel in MEPS
followed patients for about 2 years with data collected in five rounds of 4 to 5
months each. HRQoL was measured using the physical and mental component
scores of the SF-12 quality of life instrument. Baseline HRQoL wasmeasured at the
end of round 2. Incident utilization for ACEI and ARBwas determined during round
3 or 4, and outcome HRQoL was measured at the end of round 4. Analysis was
performed on two populations: patients utilizing either ACEI or ARB vs. neither;
and patients utilizing ARB vs. ACEI. Multiple linear regression models were per-
formed to test the unique effect of ACEI and ARB on the physical and mental
component of HRQoL while controlling for baseline HRQoL, comorbidities, come-
dications, demographic and socio-economic factors. RESULTS: Overall 60% of pa-
tients received either ACEI or ARB. Of the 20% of these who were incident users of
ACEI/ARB, ACEI was utilized by 65% of the patients. Multiple linear regression
models did not reveal any statistically significant effect of using ACEI or ARB vs
neither on the physical (p  0.27) or mental (p  0.47) component of HRQoL. Simi-
larly, using ACEI versus ARB did not have any statistically significant effect on the
physical (p  0.20) and mental (p  0.66) components of HRQoL. CONCLUSIONS:
ACEI and ARB, now regarded as quality of caremeasures for patients with concom-
itant hypertension and diabetes, did not seem to affect patients’ HRQoL. More
research is needed to evaluate the long term consequences of ACEI and ARB use.
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OBJECTIVES: Cardiovascular disease culminating in myocardial infarction (MI) re-
mains prevalent in society and is responsible for significant morbidity andmortal-
ity. Patients may experience a variety of deleterious effects following an MI. An
enhanced understanding of patients’ post-MI experiences may lead to improved
assessments of post-MI treatment outcomes and, ultimately, improved therapies.
METHODS: Participants were 38 patients who had experienced an MI (with or
without ST segment elevation) within the past 6 months (n17) or in the past 6-12
months (n21). One-hour in-person interviews were conducted using a semi-
structured interview guide. Interview responses were coded using ATLAS.ti soft-
ware. The percent of patientsmentioning a specific post-MI experiencewas used to
identify the most relevant and generalizable patient experiences. RESULTS: The
average age of the patients was 53 (range34-87, 63%male). Feeling tired, themost
commonly reported post-MI experience, was reported by 76% of patients. Within
this tiredness category, patients reported experiencing a loss of physical energy
(66%), mental energy (34%), and motivation (26%). A majority of patients also re-
ported dyspnea (58%). Additionally, patients reported emotional effects, including
worry (61%) and depression (58%), as well as an impact on relationships (58%) and
social activities (50%). Time since the MI had little effect on patient experiences.
CONCLUSIONS: Patients report a wide variety of negative experiences after an MI.
A loss of physical energy is only one component of the tiredness experienced by
patients; loss of mental energy and loss of motivation are also common. These
experiences may be directly related to the effects of the MI, but may also be sec-
ondary to the experience of depression and worry. Further refinement of the con-
cepts associated with the patient’s experience following an MI may yield novel
endpoints for use in clinical trials and better therapies.
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OBJECTIVES: In chronic conditions such as hypertension, health-related quality of
life (HRQoL) is an especially important outcome, given their lifelong nature and the
need for daily self-management. We aimed to assess HRQoL among people with
hypertension in Korea.METHODS: A prospective, observational study was carried
out on hypertensive patients from 21 medical centers throughout Korea. A total of
273 hypertensive patients 45-75 year-old males or 55-75 year-old females were
assessed for Health-Related QoL (HRQoL). HRQoL was assessed on 8 dimensions of
the SF-36 questionnaire. RESULTS: Patients with hypertension were 607.6 years
old (44.3% female), had hypertension for 55.2 years. In total, 39.2% had hyperten-
sion and hyperlipidemia; 12.8% had hypertension and diabetes. HRQoL physical
component mean scores (PCS) were determined as 49.77.2, and mental compo-
nent mean scores (MCS) were determined as 50.39.3. Women had consistently
lower scores on all dimensions of SF-36, indicating poorer HRQoL. There were no
significant differences by age, duration of hypertension in any of the SF compo-
nents. HRQoL MCS of patients with combined hypertension and diabetes were
lower than that of the other group (p0.021). In the hypertensive patients with
diabetes revealed poorer mental functioning compared with those with hyperlip-
idemia (HRQoLMCS: 47.09.8, 52.08.8, respectively). The scale scores (0-100 scor-
ing) in all eight dimensions of SF-36 were 81.221.7 in physical functioning,
86.223.1 in role-physical, 79.623.7 in bodily pain, 58.218.8 in general health,
62.221.0 in vitality, 89.418.3 in social function, 87.822.0 in role-emotional,
74.020.1 in mental health. CONCLUSIONS: Hypertension seems to comparably
impair HRQoL in Korea. The coexistence of hypertension and diabetes, in particu-
lar, has a more negative effect on HRQoL. The findings suggest that QoL in hyper-
tensive patients has similar trend compared to the results from national health
survey aiming at residents in Korea (Utility weight for hypertension: 0.77 from 2005
KNHANES).
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OBJECTIVES: To assess the Health related quality of life (HRQoL) in hypertensive
patients attending public hospitals in Quetta, Pakistan.METHODS: European Qual-
ity of Life scale (EQ-5D) was used for assessment of HRQoL. Descriptive statistics
were used to describe demographic and disease characteristics of the patients. Chi
square test was used to determine association among variables with (p0.05) con-
sidered as significant. HRQoL was scored using values derived from the United
Kingdom general population survey. All analyses were performed using SPSS ver-
sion 16.0. RESULTS: 385 hypertensive patients were enrolled for the study with
mean age of 39.026.596 years. Majority 186 (48.3%) were categorized in age group
of 28-37 years. 265 (68.85%) were males with 3.010.939 years of history of hyper-
tension. The mean EQ-5D descriptive score was 0.4674 0.28444 and EQ-Vas score
was 63.976.621 indicating lower health related quality of life. Education, occupa-
tion and duration of disease had significant relation with HRQoL. Bonferroni ad-
justment was done to find inter group significance. Among education, group 1 had
significant relationwith group 3, 4, and 5 (where group 1 illiterate, 3, 4 and 5 being
Primary, FA/FSc, and BA/BSc respectively). In occupation, group 3 was found sig-
nificant with group 0 and 2 (where group 3  Private Job, group 0  jobless and
group 2  Government official). For duration of disease, group 4 was found signif-
icant with group 1 and 2 (where group 4 more than 5 years, group 1 less than 1
year and group 2more than 1 year but less than 3 years). CONCLUSIONS: Lack of
health care professionals and little interaction with patients is one of the major
health problem. Patients therefore, do not have adequate knowledge about their
conditions which in turn affect their HRQoL. To overcome this issue, paramedical
staff can be utilized for counseling the patients.
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OBJECTIVES: Evaluate the impact on cardiovascular risk control and its determi-
nants in patients enrolled in the Disease Management (DM) Program “De Todo
Corazón”. METHODS: The objective the DM program is to modify cardiovascular
risk (CVR) classified according to Adult Treatment Panel III (ATPIII) methodology,
the program includes direct pharmacological intervention, integratedwith promo-
tion and prevention activities. This program began in 2004 and 27,596 patients
corresponding to a dynamic cohort have received its benefits from it up to Decem-
ber 2009. The effectiveness of the program was assessed through the analysis of
trends in the CVR marker variables and goals accomplishments. The study popu-
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lation corresponds to participating subjects since 2004 who received continuous
annual follow-up visits until 2009. The trend analysis of the different risk factors
over time was performed, as well as the estimate of the annual CVR using ATPIII
categories (High, moderate and lower risk). RESULTS: 3,870 subjects were included
in the assessment with a mean age of 62 years (SD11.52) and the majority of
subjects are women (73%). The results showed a reduction of 30% in smoking. In
addition, over the past 5 years, blood pressure (BP) diminished consistently
through risk groups (mean reduction of 14 mmHg); LDL cholesterol levels were
reduced within high and moderate risk groups (mean reduction of 25 mg/dl) and
the speed of kidney damage progression decreased. Complementary analyses with
an extended cohort containing over 8,000 patients exhibited similar results.
CONCLUSIONS: Cardiovascular Risk DM Program “De Todo Corazón” showed a
meaningful impact to modify risk factors in Colombian patients such as smoking,
BP, lipid profile and kidney risk. The results of a wider cohort supported that ob-
served positive outcomes trends were generated by this program.
PCV80
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OBJECTIVES:Todetermine the health care utilization andpotential cost savings for
an employer-sponsored medication therapy management (MTM) program.
METHODS: A prospective, pre-post longitudinal study. Employees included in the
study were Lucas County employees and their dependents who had diabetes, hy-
pertension, hyperlipidemia, or a combination of the three. The MTM services were
provided by independent pharmacists from seven sites in Northwest Ohio. Vari-
ables measured included social measures (alcohol consumption, tobacco con-
sumption, exercise, caffeine consumption) and process measures (specialty phy-
sician visits, sick days, emergency room visits, flu shot, hypoglycemic events, and
self-monitoring of blood glucose). Difference in disease-related spending, pre-and
post joining MTM program were analyzed for employees who improved, did not
improve or showed negative improvement at their final recorded visit for process
measures. Data was analyzed using SPSS v17.0 and Microsoft Excel. RESULTS:
There was an overall trend of improvement in both the social and process mea-
sures being measured. All three specialty physician visits have increased: podia-
trist visits by 24%, ophthalmologist visits by 41%, and dentist visits by 26%. Average
cost savings for employees who improved or maintained appropriate utilization,
ranged from $931.67 to $1437.77 per employee per two years. Approximately 90% of
employees either took less or had the same amount of sick days. Employees who
had fewer sick days saved almost $1230.79 per employee while employees who
took more sick days spent approximately $2146.51 per employee. Employee utili-
zation of flu shots have been substantial, with 70% getting a flu shot at least once
over the 24 months. Alcohol and tobacco consumption decreased by 50% and 55%,
respectively. Caffeine use decreased by 26.47%. Reported exercise increased by
39%. CONCLUSIONS: Interaction with the pharmacist has had a positive impact on
employees’ outcomes related to social and process measures, which might also be
helpful in causing reduction in cost burden to the employer.
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OBJECTIVES: To assess the impact of an employer-sponsored, pharmacist-pro-
vided MTM program on clinical outcomes in patients with diabetes and hyperten-
sion over a 24 month period. METHODS: A prospective, intent-to-treat, pre-post
longitudinal study. Patients were Lucas County employees and dependents with
diabetes, hypertension, or a combination. The MTM services were provided by
independent pharmacists in Northwest Ohio at seven sites. ADA and JNC-VII
guidelines were used to design interventions and set patient goals. Data was ana-
lyzed using SPSS v17.0. Friedman testwas used to compare readings at baseline, 12,
and 24months. RESULTS: To date 623 patients have enrolled in the MTM program,
41 with diabetes only, 224 with diabetes and one or more comorbidities, 85 with
hypertension only, and 101 with hypertension with comorbidities. A total of 190
patients with A1C values and 412 patients with blood pressure values were ana-
lyzed.MeanA1C values increased from 7.14 1.53 to 7.28 1.52 for all patients. For
uncontrolled patients, A1C decreased from 8.40  1.57 to 8.03  1.63. Diabetes
patients decreased systolic blood pressure (SBP) from 133.59  19.57 to 129.65 
16.04 and diastolic blood pressure (DBP) from 81.95  10.38 to 79.49  8.72. Uncon-
trolled patients decreased SBP from 147.65  16.62 to 134.02  14.99 and DBP de-
creased from 87.65  6.66 to 82.31  8.31. Hypertensive patients decreased SBP
from 134.42  17.28 to 129.86  14.13 and DBP from 84.76  10.97 to 81.76  10.10.
Uncontrolled hypertensive patients decreased SBP from 151.89  11.10 to 134.95 
12.56 and DBP from 98.27 6.24 to 85.71 11.86. CONCLUSIONS: The pharmacists’
efforts have been shown to help decrease mean A1C and BP in patients. The im-
provements in these values help to decrease the risk for related complications and
additional employer costs.
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OBJECTIVES: To assess the relationship between integration of services and the
management of hypertensive patients within select physician organizations in the
U.S.METHODS:Amodified version of the Physician Practice Connection Readiness
Survey (PPC-RS), developed by the National Committee for Quality Assurance
(NCQA), was administered to chief medical officers at 28 U.S.-based physician or-
ganizations in 2010. The integration score included structural, functional, and fi-
nancial sub-domains with possible scores of 0 to 100; a higher score indicating
greater integration of services. Demographic and clinical data were collected from
a random sample of 300 hypertensive adults selected for chart review at each
participating organization. Site characteristics and integration scores were re-
ported. Hierarchical regression models were estimated to assess the association
between an organization’s integration score and patients’ outcomes. RESULTS: Of
the 28 participating sites, most had electronic medical records functions (71.4%)
and hadmore than 50 staffmembers (78.6%). The average integration scorewas 46,
with mean scores of 64, 33 and 42 for the structural, financial, and functional
sub-domains, respectively. Integration scores were generally higher in sites with
50 physicians as compared to sites with 50 physicians (52.8 vs. 36.6, respec-
tively), and were also higher in sites owned by hospitals. Among the 8,400 patients
reviewed, approximately 60.5% had controlled BP. A positive correlation was ob-
served between integration scores and controlled BP (Pearson coefficient  0.39,
p0.05). Additionally, patient BP control was better in organizations with integra-
tion scores in the highest quartile (64.3%) than in sites in the lowest quartile
(56.8%). Although the point estimates were not significant in the hierarchical
model, regression analyses suggested that higher integration scores were associ-
ated with better BP control outcomes. CONCLUSIONS: This study provides some
evidence that better integration of service in physician organizations is associated
with better patient outcomes as reported via the PPC-RS.
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OBJECTIVES: Antiplatelet therapies with aspirin, ADP receptor inhibitors, and gly-
coprotein IIb/IIIa inhibitors play an important role in management of acute coro-
nary syndromes and chronic coronary heart disease. An assessment of the litera-
ture was conducted to identify evidence gaps and critical unmet needs in
antiplatelet therapy in the management of ACS and chronic CHD. METHODS: A
targeted literature search was conducted on antiplatelet therapy with a focus on
ADP receptor inhibitors using PubMed, Medline and Google Scholar. Parallel
searches were initiated for the ACS and chronic CHD. Additional references were
identified and included based on citations from reviewed articles. A total of 179
articles were reviewed. Article types considered in the study included review arti-
cles, clinical trials, observational studies, and economic evaluations.RESULTS:The
review identified gaps and unmet needs in drug therapy for ACS and chronic CHD
using established (aspirin, clopidogrel, and glycoprotein IIb/IIIa agents) and newer
drugs (prasugrel and ticagrelor). Key evidentiary gapswere identified on the impact
of clopidogrel resistance, antiplatelet associatedmajor, minor and nuisance bleed-
ing risk, impact on humanistic outcomes, long term cost-effectiveness, impact on
elderly patients and other high risk subpopulations. Our assessment revealed that
current antiplatelet therapies are associated with significant downsides, such as
increased bleeding risks as well as other untoward effects. CONCLUSIONS: Our
assessment revealed important gaps and areas of unmet need associated with
current and new antiplatelet therapies in the management of ACS and chronic
CHD. Further studies should be conducted to address these evidentiary gaps, while
unmet patient needs should be taken into consideration in future drug develop-
ment.
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OBJECTIVES: To report the effectiveness of a CME intervention to improve appro-
priate care for hypertension, which in turn has a positive effect on blood pressure
control of hypertensive patients in primary care clinics. METHODS: A secondary
data analysis was carried out using data of hypertensive patients treated by family
doctors who participated in the CME intervention. The evaluation was designed as
a pre-/post-intervention study with control group in six primary care clinics. The
effect of the CME intervention was analysed using multiple logistic regression
modelling in which the dependent variable was uncontrolled blood pressure in the
postintervention patient measurement. The model was adjusted by considering
the family doctors as a cluster unit. This allowed correcting the effect of including
several patients who received treatment by the same doctor. Selection of regres-
sion variables was carried out by comparing 2 values of the log likelihood in the
models; this was carried out by using the backward stepwise procedure. Goodnes-
sof-fit of the model was evaluated using the Hosmer–Lemeshow test. RESULTS:
After the CME intervention, the net reduction of uncontrolled blood pressure be-
tween stages in the intervention group was 10.3%. The model results were that
being treated by a family doctor who participated in the CME intervention reduced
by 53% the probability of lack of control of blood pressure; receiving dietary recom-
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